Journal of Biological Chemistry · 1997 · 98 citations · 33 references
Life SciencesMolecular BiologyOncologyCell ProliferationCell SignalingSignal TransductionCancer Cell SignalingGrowth Factor SignalingSignal Transduction In CancerCell Growth RegulationEpidermal Growth Factor Receptor SignalingGrowth Factor-receptor InteractionsGrowth FactorsLigand-induced DimerizationReceptor AutophosphorylationReceptor Dimerization
Growth factor receptors of the epidermal growth factor (EGF) receptor family play pivotal roles in the regulation of cell proliferation and differentiation and are involved in the development of human cancers. It has been well documented that these receptors undergo growth factor-stimulated homo- and heterodimerization as a first step in the initiation of signaling cascades. Here we provide evidence for a new mechanism for growth factor-stimulated receptor dimer formation, designated secondary dimerization. The growth factor-induced dimerization and ensuing receptor trans-autophosphorylation results in the dissociation of the original (primary) receptor dimer. Each phosphorylated receptor monomer then interacts with a new (nonphosphorylated) receptor to form a secondary dimer. Treatment of cells with EGF yields Neu-ErbB3 secondary dimers, and heregulin treatment induces the formation of Neu-EGF receptor (secondary) dimers. The ability of EGF and heregulin to stimulate a cascade of dimerization events points to a novel mechanism by which multiple signaling activities and diverse biological responses are initiated by members of the EGF receptor family. Growth factor receptors of the epidermal growth factor (EGF) receptor family play pivotal roles in the regulation of cell proliferation and differentiation and are involved in the development of human cancers. It has been well documented that these receptors undergo growth factor-stimulated homo- and heterodimerization as a first step in the initiation of signaling cascades. Here we provide evidence for a new mechanism for growth factor-stimulated receptor dimer formation, designated secondary dimerization. The growth factor-induced dimerization and ensuing receptor trans-autophosphorylation results in the dissociation of the original (primary) receptor dimer. Each phosphorylated receptor monomer then interacts with a new (nonphosphorylated) receptor to form a secondary dimer. Treatment of cells with EGF yields Neu-ErbB3 secondary dimers, and heregulin treatment induces the formation of Neu-EGF receptor (secondary) dimers. The ability of EGF and heregulin to stimulate a cascade of dimerization events points to a novel mechanism by which multiple signaling activities and diverse biological responses are initiated by members of the EGF receptor family. The interactions of various growth factors and cytokines with cell surface receptor tyrosine kinases initiate a variety of intracellular signaling pathways that when integrated yield cell cycle progression, cell differentiation, or apoptosis. Several classes of receptor tyrosine kinases have been described, among which the EGFR family is of particular interest, because these receptors have been implicated in malignant transformation (1Alimandi M. Romano A. Curia M.C. Muraro R. Fedi P. Aaronson S.A. Di F.P. Kraus M.H. Oncogene. 1995; 10: 1813-1821Google Scholar, 2Earp H.S. Dawson T.L. Li X. Yu H. Breast Cancer Res. Treat. 1995; 35: 115-132Google Scholar, 3Gullick W.J. Marsden J.J. Whittle N. Ward B. Bobrow L. Waterfield M.D. Cancer Res. 1986; 46: 285-292Google Scholar, 4Mitra A.B. Murty V.V.V.S. Pratap M. Sodhani P. Chaganti R.S.K. Cancer Res. 1994; 54: 637-639Google Scholar, 5Slamon D.J. Clark G.M. Wong S.G. Levin W.J. Ullrich A. McGuire W.L. Science. 1987; 235: 177-182Google Scholar, 6Slamon D.J. Godolphin W. Jones L.A. Holt J.A. Wong S.G. Keith D.E. Levin W.J. Stuart S.G. Udove J. Ullrich A. Press M.F. Science. 1989; 244: 707-712Google Scholar, 7Wallasch C. Weiss F.U. Niederfellner G. Jallal B. Issing W. Ullrich A. EMBO J. 1995; 14: 4267-4275Google Scholar, 8Zhou D. Battifora H. Yokota J. Yamamoto T. Cline M.J. Cancer Res. 1987; 47: 6123-6125Google Scholar). This family includes the epidermal growth factor (EGF) 1The abbreviations used are: EGF, epidermal growth factor; EGFR, EGF receptor; HRG, heregulin. receptor (also referred to as ErbB1), the Neu/ErbB2 protein (referred to from here on as Neu), and the more recently identified ErbB3 and ErbB4 proteins (9Coussens L. Yang-Feng T.L. Liao Y.C. Chen E. Gray A. McGrath J. Seeburg P.H. Libermann T.A. Schlessinger J. Francke U. Levinson A. Ullrich A. Science. 1985; 230: 1132-1139Google Scholar, 10Das M. Miyakawa T. Fox C.F. Pruss R.M. Aharonov A. Herschman H.R. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 2790-2794Google Scholar, 11Kraus M.H. Issing W. Miki T. Popescu N.C. Aaronson S.A. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 9193-9197Google Scholar, 12Plowman G.D. Culouscou J.M. Whitney G.S. Green J.M. Carlton G.W. Foy L. Neubauer M.G. Shoyab M. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 1746-1750Google Scholar). Two types of ligands interact with members of the EGFR family; EGF is a prototype for ligands that bind to the EGFR, and heregulin (HRG) or Neu differentiation factor represents a family of ligands that bind to both ErbB3 and ErbB4 (10Das M. Miyakawa T. Fox C.F. Pruss R.M. Aharonov A. Herschman H.R. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 2790-2794Google Scholar, 13Carraway III, K.L. Sliwkowski M.X. Akita R. Platko J.V. Guy P.M. Nuijens A. Diamonti A.J. Vandlen R.L. Cantley L.C. Cerione R.A. J. Biol. Chem. 1994; 269: 14303-14306Google Scholar, 14Carraway III, K.L. Cantley L.C. Cell. 1994; 78: 5-8Google Scholar, 15Plowman G.D. Green J.M. Culouscou J.M. Carlton G.W. Rothwell V.M. Buckley S. Nature. 1994; 366: 473-475Google Scholar). Two of the receptors, EGFR and ErbB4, are capable of ligand-stimulated tyrosine kinase activity. Thus far, the Neu tyrosine kinase is an orphan receptor, whereas ErbB3 appears to be a kinase-defective receptor (14Carraway III, K.L. Cantley L.C. Cell. 1994; 78: 5-8Google Scholar, 16Pinkas-Kramarski R. Soussan L. Waterman H. Levkovitz G. Alroy I. Klapper L. Lavi S. Seger R. Rats Rtzkin B.J. Sela M. Yarden Y. EMBO J. 1996; 15: 2452-2467Google Scholar). The binding of EGF or HRG to their receptors results in receptor dimerization and receptor trans-autophosphorylation. The phosphorylated receptors recruit cellular signaling proteins, through the binding of their Src homology 2 or phosphotyrosine binding domains and thus initiate signaling pathways (17Carpenter G. Cohen S. Annu. Rev. Biochem. 1979; 48: 193-216Google Scholar, 18Ullrich A. Schlessinger J. Cell. 1990; 61: 203-212Google Scholar). The binding of EGF stimulates the formation of both EGFR homodimers or heterodimers like EGFR-Neu (19Yarden Y. Schlessinger J. Biochemistry. 1987; 26: 1443-1451Google Scholar, 20King C.R. Borrello I. Bellot F. Comoglio P. Schlessinger J. EMBO J. 1988; 7: 1647-1651Google Scholar, 21Goldman R. Levy R.B. Peles E. Yarden Y. Biochemistry. 1990; 29: 11024-11028Google Scholar). Similarly, HRG can stimulate receptor homodimer formation of ErbB3 or of ErbB4 as well as receptor heterodimers like ErbB3 and Neu or ErbB4 and Neu (13Carraway III, K.L. Sliwkowski M.X. Akita R. Platko J.V. Guy P.M. Nuijens A. Diamonti A.J. Vandlen R.L. Cantley L.C. Cerione R.A. J. Biol. Chem. 1994; 269: 14303-14306Google Scholar, 15Plowman G.D. Green J.M. Culouscou J.M. Carlton G.W. Rothwell V.M. Buckley S. Nature. 1994; 366: 473-475Google Scholar). The HRG-promoted formation of these heterodimers provides the molecular basis for the stimulation of Neu tyrosine kinase activity (7Wallasch C. Weiss F.U. Niederfellner G. Jallal B. Issing W. Ullrich A. EMBO J. 1995; 14: 4267-4275Google Scholar, 13Carraway III, K.L. Sliwkowski M.X. Akita R. Platko J.V. Guy P.M. Nuijens A. Diamonti A.J. Vandlen R.L. Cantley L.C. Cerione R.A. J. Biol. Chem. 1994; 269: 14303-14306Google Scholar, 15Plowman G.D. Green J.M. Culouscou J.M. Carlton G.W. Rothwell V.M. Buckley S. Nature. 1994; 366: 473-475Google Scholar, 22Lewis G.D. Lofgren J.A. McMurtrey A.E. Nuijens A. Fendly B.M. Bauer K.D. Sliwkowski M.X. Cancer Res. 1996; 56: 1457-1465Google Scholar). The mode of heterodimerization between members of the EGFR family may have a significant influence on malignant transformation. For example, the co-expression of ErbB3 and Neu in NIH3T3 cells results in neoplastic transformation, whereas neither the expression of ErbB3 nor Neu alone is sufficient for transformation (1Alimandi M. Romano A. Curia M.C. Muraro R. Fedi P. Aaronson S.A. Di F.P. Kraus M.H. Oncogene. 1995; 10: 1813-1821Google Scholar, 7Wallasch C. Weiss F.U. Niederfellner G. Jallal B. Issing W. Ullrich A. EMBO J. 1995; 14: 4267-4275Google Scholar). The heterodimerization of the EGFR with Neu results in cell transformation, whereas the replacement of wild type Neu by its kinase-defective counterpart abrogates transformation (2Earp H.S. Dawson T.L. Li X. Yu H. Breast Cancer Res. Treat. 1995; 35: 115-132Google Scholar, 23Qian X. Dougall W.C. Hellman M.E. Greene M.I. Oncogene. 1994; 9: 1507-1514Google Scholar). Moreover, the expression of Neu in breast and ovarian carcinomas correlates with a poor prognosis (1Alimandi M. Romano A. Curia M.C. Muraro R. Fedi P. Aaronson S.A. Di F.P. Kraus M.H. Oncogene. 1995; 10: 1813-1821Google Scholar, 2Earp H.S. Dawson T.L. Li X. Yu H. Breast Cancer Res. Treat. 1995; 35: 115-132Google Scholar, 5Slamon D.J. Clark G.M. Wong S.G. Levin W.J. Ullrich A. McGuire W.L. Science. 1987; 235: 177-182Google Scholar, 6Slamon D.J. Godolphin W. Jones L.A. Holt J.A. Wong S.G. Keith D.E. Levin W.J. Stuart S.G. Udove J. Ullrich A. Press M.F. Science. 1989; 244: 707-712Google Scholar). The molecular basis for this is likely due to an enhanced tendency of the orphan Neu receptor to form heterodimers with other members of the EGFR family (16Pinkas-Kramarski R. Soussan L. Waterman H. Levkovitz G. Alroy I. Klapper L. Lavi S. Seger R. Rats Rtzkin B.J. Sela M. Yarden Y. EMBO J. 1996; 15: 2452-2467Google Scholar, 22Lewis G.D. Lofgren J.A. McMurtrey A.E. Nuijens A. Fendly B.M. Bauer K.D. Sliwkowski M.X. Cancer Res. 1996; 56: 1457-1465Google Scholar,24Beerli R.R. Hynes N.E. J. Biol. Chem. 1996; 271: 6071-6076Google Scholar). In this study we present evidence for a new mode of inter-receptor interaction, designated secondary dimerization. Our results show that ligand-induced dimer formation might be followed by dimer dissociation and interaction of the individual, activated receptors with inactive receptors to form new, secondary dimers. Rat pheochromocytoma PC12 cell line I77.2 (25Gamett D.C. Cerione R.A. FEBS Lett. 1994; 351: 335-339Google Scholar, 26Gamett D.C. Greene T. Wagreich A. Kim H.H. Koland J.G. Cerione R.A. J. Biol. Chem. 1995; 270: 19022-19027Google Scholar) was used in this study. Recombinant heregulin (rHRG-β1177–241) was provided by Dr. Mark Sliwkowski (Genetech, Inc.), and EGF was purchased from Sigma. Anti-EGFR polyclonal antibodies (SC 03) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), anti-c-Neu monoclonal antibodies (Ab-4) were from Calbiochem (San Diego, CA), anti-ErbB3 (2F12) and anti-c-ErbB4 (AB-2) monoclonal antibodies were from Neo Markers (Fremont, CA), and anti-phosphotyrosine monoclonal antibodies (PY20) were from Transduction Laboratories (Lexington, KY). Antibodies were tested for their specificity, and no cross-reactivity was detected. Tyrphostins were purchased from Calbiochem (San Diego, CA). PC12 cells were grown on 15-cm plastic dishes in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% heat-inactivated horse serum and 5% fetal bovine serum (Atlanta Biologicals, Norcross, GA), 100 units/ml of penicillin, 100 μg/ml streptomycin, and 0.25 μg/ml Amphotericin B (Sigma) in a CO2 incubator (5% CO2) at 37 °C. Cell stimulation, immunoprecipitation, and Western blotting were carried out as described previously (26Gamett D.C. Greene T. Wagreich A. Kim H.H. Koland J.G. Cerione R.A. J. Biol. Chem. 1995; 270: 19022-19027Google Scholar). Nearly confluent cell cultures were incubated for 16–20 h in growth medium containing 0.1% serum. Then the cells were gently detached by a short incubation with Hanks' balanced salt solution (without calcium or magnesium), centrifuged at 500 × g for 5 min, and resuspended in serum-free growth medium. The use of cell suspensions enables the stimulation of a large number of cells in each sample. In control experiments, we did not find a difference between the results obtained when using either attached cells or suspended cells. 2D. Gamett, unpublished data. Cells were dispensed at 1.0 × 107 cells/1.5 ml in Eppendorf tubes, and HRG or EGF (20 nm or 100 ng/ml, respectively) was added to of the for 2 at 37 °C. Cells to treatment with tyrosine kinase were for 2 at 37 with the of the growth Tyrphostins and were added to of and The were by the to followed by to the cells and of the medium. The cell were with containing 10% μg/ml μg/ml and of incubation on the cell were centrifuged for at × g to Antibodies were then added to the as for each followed by of a of protein The were incubated for h in the with and then the were by with and for in of The were to and to The were by h of incubation with bovine serum in with and incubated for h with antibodies as were by using secondary antibodies and of tyrosine kinase activity in the was as described previously N. A. C. A. J. Biol. Chem. 1993; Scholar). Cell cell to either HRG or EGF, cell and were carried out as described for Each was with a containing and resuspended in of the The was initiated by the of of to of containing 2 of and of the either or at the of and The were for at and were by the of of The were and the were to which were incubated in 10% containing at with The were then and in a of tyrosine kinase activity of receptors in cells were carried out as described previously P.M. III, K.L. Cerione R.A. J. Biol. Chem. Scholar, P.M. Platko J.V. Cantley L.C. Cerione R.A. III, K.L. Proc. Natl. Acad. Sci. U. S. A. 1994; Scholar). from cells with P.M. III, K.L. Cerione R.A. J. Biol. Chem. Scholar) either or was obtained from L. of Cell were incubated for at in a containing 5 and 5 of The was by the of of 5 × Nature. and were to of were from the and the was in a P.M. III, K.L. Cerione R.A. J. Biol. Chem. Scholar, P.M. Platko J.V. Cantley L.C. Cerione R.A. III, K.L. Proc. Natl. Acad. Sci. U. S. A. 1994; Scholar). were in cells with the receptor not in cells or in cells with the wild type as was by Western for a new mode of inter-receptor interactions between members of the EGFR family were obtained a study of the of of tyrosine kinase activity A. A. Science. 1995; on receptor dimerization and tyrosine kinase activity in PC12 cells. In these experiments, cells were to EGF or HRG and then to and by or The tyrosine kinase activity in the was by the a of EGFR, and by which Neu in various cells N. A. C. A. J. Biol. Chem. 1993; Scholar, A. A. Science. 1995; Scholar, A. N. I. A. C. A. J. Chem. 1993; Scholar, N. A. J. Biochem. 1994; PC12 cells M. L. A. A. Biochemistry. 1993; Scholar). The results of these that both the EGFR and Neu tyrosine kinase activities were present in and were with in other cell types (16Pinkas-Kramarski R. Soussan L. Waterman H. Levkovitz G. Alroy I. Klapper L. Lavi S. Seger R. Rats Rtzkin B.J. Sela M. Yarden Y. EMBO J. 1996; 15: 2452-2467Google Scholar, 21Goldman R. Levy R.B. Peles E. Yarden Y. Biochemistry. 1990; 29: 11024-11028Google as well as in PC12 which that EGF treatment the formation of EGFR-Neu This was by the in the tyrosine kinase activity in was to both the EGFR and Neu the results obtained with EGFR and Neu from PC12 the obtained from cells were In of Neu from PC12 cells tyrosine kinase activity that was not to the Neu kinase to the EGFR kinase This the that EGFR is present in HRG not as a for from PC12 cells to the Neu kinase in to the EGFR kinase the of Neu in the of on tyrosine kinase activity of tyrosine as with cells were with a and and receptors were kinase activity was in the as described and and in N. A. C. A. J. Biol. Chem. 1993; activity of tyrosine as with cells. in a new PC12 cells were with a and and receptors were kinase activity was in the as described and and in N. A. C. A. J. Biol. Chem. 1993; cell expression for members of the EGFR family or we have that a for Neu EGFR and is of ErbB4 activity both and which were to be for the EGFR A. A. Science. 1995; N. A. J. Biochem. 1994; are capable of ErbB4 tyrosine kinase activity of on tyrosine kinase activity of receptors in of a in the tyrosine kinase as with control for the of the activities are described and and in P.M. III, K.L. Cerione R.A. J. Biol. Chem. and P.M. Platko J.V. Cantley L.C. Cerione R.A. III, K.L. Proc. Natl. Acad. Sci. U. S. A. 1994; of a in a new The in the tyrosine kinase as with control for the of the activities are described and and in P.M. III, K.L. Cerione R.A. J. Biol. Chem. and P.M. Platko J.V. Cantley L.C. Cerione R.A. III, K.L. Proc. Natl. Acad. Sci. U. S. A. 1994; for the results obtained with the was that HRG the formation of an in which the tyrosine kinase activity of ErbB4 be to Thus far, we have not been to the formation of a in PC12 cells through Western using which not be with the was that HRG the formation of a In as in from PC12 cells EGFR, as well as Neu and induces the of Neu with PC12 cells in were for in serum-free growth and suspended in serum-free medium. cell were for 2 with or Then the cells were for 2 with HRG (20 and and the cell were to using The were to and Western blotting with followed by secondary The were by cell stimulation by HRG results in the formation of the followed by dimer and interaction of the Neu with EGFR to form the secondary The the tyrosine kinase activity of Neu and thus the dissociation of the dimer Neu-ErbB3 and the formation of the secondary dimer The EGFR tyrosine kinase activity and thus the dissociation of the secondary dimer and and the described in was to a blotting with anti-phosphotyrosine neither the EGFR nor Neu HRG, these that the EGFR-Neu is a secondary of a heterodimerization by that the in the dimer might be followed by dimer dissociation and interaction between activated Neu and a This is in with in which we have that HRG stimulates the heterodimerization between ErbB3 and Neu in PC12 cells that the of from Neu and a with the of the (26Gamett D.C. Greene T. Wagreich A. Kim H.H. Koland J.G. Cerione R.A. J. Biol. Chem. 1995; 270: 19022-19027Google Scholar). these results to that the (primary) was not of that the of the receptor the dimer thus the to interact with other signaling In the phosphorylated receptors may bind to Src homology 2 proteins like In other the phosphorylated can interact with other (nonphosphorylated) receptor to form secondary dimers. this were we that treatment with of tyrosine kinase activity A. A. Science. 1995; have on the formation of secondary receptor dimers. The in 2 and show that this in was the The treatment of PC12 cells with which is a and for EGFR in various cells the formation of the secondary treatment with the Neu tyrosine kinase A. A. Science. 1995; N. A. J. Biochem. 1994; Scholar, M. L. A. A. Biochemistry. 1993; the formation of the secondary dimer. are with the in B. the by Neu tyrosine kinase both the of Neu and the of ErbB3 and thus the dissociation of the Neu-ErbB3 dimer. the formation of secondary by the EGFR tyrosine kinase the of Neu the secondary the dissociation of this and its 2 the results of a Western of Neu using an anti-phosphotyrosine and 2 show that HRG treatment of PC12 cells the tyrosine of the receptors present in the This was by 2 which that the of the an the secondary dimer. The tyrosine of Neu was by which that Neu a of the tyrosine of The in provide evidence for the formation of type of secondary dimer. In this the stimulation of PC12 cells with EGF to the formation of a dimer between Neu and because neither of these receptors bind EGF, this dimerization be the secondary of a dimerization between the EGFR and The formation of this secondary receptor dimer was by the EGFR and by the Neu results are with the in B. The of (secondary) Neu-ErbB3 dimer formation by that the of Neu is for the dissociation of Neu from the EGFR the The of (secondary) Neu-ErbB3 dimer formation by that Neu and EGFR are for the dissociation of the EGFR-Neu dimer. The in are with the that Neu is phosphorylated by the EGFR the EGFR-Neu as by of tyrosine by Neu to a because a with containing EGFR, and Neu have that the EGFR can is or no of the Guy and unpublished data. The in the results of of ErbB3 with Neu from PC12 cells with HRG cells with The HRG stimulation to the formation of an (primary) and as previously this yields a in the ErbB3 Western that tyrosine of ErbB3 (26Gamett D.C. Greene T. Wagreich A. Kim H.H. Koland J.G. Cerione R.A. J. Biol. Chem. 1995; 270: 19022-19027Google Scholar). The is with (26Gamett D.C. Greene T. Wagreich A. Kim H.H. Koland J.G. Cerione R.A. J. Biol. Chem. 1995; 270: 19022-19027Google to the that this represents a phosphorylated form of ErbB3 that from Neu and a with EGF induces the formation of a Neu-ErbB3 secondary dimer. In this the ErbB3 Western a with a to the ErbB3 obtained in cells. these results that the tyrosine of ErbB3 Neu-ErbB3 heterodimers on is a Neu-ErbB3 or a secondary and these have the that are to is the of growth factor-stimulated receptor dimer formation in the of members of the EGFR family or in the activities of a variety of other receptor tyrosine have that receptor and dimerization are on the type R.R. Hynes N.E. J. Biol. Chem. 1996; 271: 6071-6076Google Scholar) and that receptor dimerization is not a is to a (16Pinkas-Kramarski R. Soussan L. Waterman H. Levkovitz G. Alroy I. Klapper L. Lavi S. Seger R. Rats Rtzkin B.J. Sela M. Yarden Y. EMBO J. 1996; 15: 2452-2467Google Scholar, R.R. Hynes N.E. J. Biol. Chem. 1996; 271: 6071-6076Google Scholar). The in this study provide evidence that growth factors can stimulate a cascade of receptor dimerization events through a mechanism that the of the interactions between members of the EGFR family. that growth factor-stimulated receptor dimerization represents a a The of receptor the by its receptor results in the dissociation of the receptor dimer to the dissociation of an This enables the individual, to form new receptor and to new that a variety of and secondary receptor dimer are on the used and the In the present we show that treatment of PC12 cells with HRG not to the formation of an receptor dimer to a secondary dimer and that treatment with EGF induces both a EGFR-Neu and a secondary Neu-ErbB3 of and secondary by ligands and receptors are present in secondary the in a new receptors are present in secondary the The that receptor dimerization can to secondary dimerization events is by various other of study. to obtained from PC12 cells were with the that the receptor dimer between ErbB3 and Neu was of a and dissociation to interactions (26Gamett D.C. Greene T. Wagreich A. Kim H.H. Koland J.G. Cerione R.A. J. Biol. Chem. 1995; 270: 19022-19027Google Scholar). study of the dimerization of the EGFR has that phosphorylated receptor dimerization (19Yarden Y. Schlessinger J. Biochemistry. 1987; 26: 1443-1451Google Scholar). This of phosphorylated EGFR with the formation of phosphorylated be to the dissociation of the EGFR have with the that members of the EGFR family can phosphorylated and activated in a in a to the formation of secondary dimerization events between a receptor monomer and a receptor has recently been that both the EGFR and Neu can be phosphorylated and activated of EGF or by ligands for receptors, through a mechanism a tyrosine kinase from the and the EGFR or Neu H. Weiss F.U. C. Ullrich A. Nature. 1996; Scholar). The secondary dimer formation is in with the that Neu is to by both EGF and HRG receptors EMBO J. 1988; 7: Scholar, E. E. N. D. Yarden Y. EMBO J. 1993; Scholar, D. E. R.R. Chen X. B.J. Seger R. Hynes N.E. Yarden Y. EMBO J. 1996; 15: Scholar) as well as with the of signaling the cell by receptor interactions (16Pinkas-Kramarski R. Soussan L. Waterman H. Levkovitz G. Alroy I. Klapper L. Lavi S. Seger R. Rats Rtzkin B.J. Sela M. Yarden Y. EMBO J. 1996; 15: 2452-2467Google Scholar). The ability to undergo both and secondary receptor dimerization events provide a by which each of the EGFR family form a of phosphorylated receptor on the types of and secondary receptor that are the of signaling pathways that can be initiated by a growth In the by secondary receptor cells that have been to the first of from the receptor dimerization is that the of might stimulate or and or the by the first of the mechanism of secondary dimerization provides an for control and for of initiated by the members of the EGFR family. for
33
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations